Shivakumar S, Sahu K, Rao R, Gv C, Philipose C, Rai S
Iran J Pathol. 2024; 19(2):236-243.
PMID: 39118789
PMC: 11304467.
DOI: 10.30699/IJP.2024.2008693.3154.
Almeida-Nunes D, Nunes M, Osorio H, Ferreira V, Lobo C, Monteiro P
Biochem Biophys Rep. 2024; 39:101755.
PMID: 38974022
PMC: 11225207.
DOI: 10.1016/j.bbrep.2024.101755.
Qiao Y, Chen Z, Li W, Li H, Zhou L
Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(12):10049-10059.
PMID: 38967825
DOI: 10.1007/s00210-024-03260-y.
Nobel S, Swapno S, Hossain M, Safran M, Alfarhood S, Kabir M
Tomography. 2024; 10(1):105-132.
PMID: 38250956
PMC: 11154515.
DOI: 10.3390/tomography10010010.
Kundu R, Shastri M, Gupta P, Gupta N, Srinivasan R, Dey P
Cytojournal. 2023; 20:14.
PMID: 37405308
PMC: 10316228.
DOI: 10.25259/Cytojournal_30_2022.
SPON1 is an independent prognostic biomarker for ovarian cancer.
Miyakawa R, Kobayashi M, Sugimoto K, Endo Y, Kojima M, Kobayashi Y
J Ovarian Res. 2023; 16(1):95.
PMID: 37179355
PMC: 10182672.
DOI: 10.1186/s13048-023-01180-8.
Detection and Genotyping of Human Papillomavirus (HPV16/18), Epstein-Barr Virus (EBV), and Human Cytomegalovirus (HCMV) in Endometrial Endometroid and Ovarian Cancers.
Grabarek B, Ossowski P, Czarniecka J, Ozog M, Prucnal J, Dziuba I
Pathogens. 2023; 12(3).
PMID: 36986319
PMC: 10053580.
DOI: 10.3390/pathogens12030397.
Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study.
Gao Y, Liu C, Li H, Xiong X, Li G, In t Veld S
Protein Cell. 2023; 14(6):579-590.
PMID: 36905391
PMC: 10246718.
DOI: 10.1093/procel/pwac056.
Immune Tumor Microenvironment in Ovarian Cancer Ascites.
Almeida-Nunes D, Mendes-Frias A, Silvestre R, Dinis-Oliveira R, Ricardo S
Int J Mol Sci. 2022; 23(18).
PMID: 36142615
PMC: 9504085.
DOI: 10.3390/ijms231810692.
The Biological Relevance of NHERF1 Protein in Gynecological Tumors.
Sonnessa M, Sergio S, Saponaro C, Maffia M, Vergara D, Zito F
Front Oncol. 2022; 12:836630.
PMID: 35223518
PMC: 8878902.
DOI: 10.3389/fonc.2022.836630.
SOX9: Advances in Gynecological Malignancies.
Chen H, He Y, Wen X, Shao S, Liu Y, Wang J
Front Oncol. 2021; 11:768264.
PMID: 34881182
PMC: 8645898.
DOI: 10.3389/fonc.2021.768264.
Survival Is Related to Estrogen Signal Transduction Pathway Activity in Postmenopausal Women Diagnosed with High-Grade Serous Ovarian Carcinoma.
van Lieshout L, van der Ploeg P, Wesseling-Rozendaal Y, van de Stolpe A, Bosch S, Lentjes-Beer M
Cancers (Basel). 2021; 13(20).
PMID: 34680250
PMC: 8533979.
DOI: 10.3390/cancers13205101.
Livin/BIRC7 gene expression as a possible diagnostic biomarker for endometrial hyperplasia and carcinoma.
Elmekkawy B, Shoaib R, Seleem A, Shaalan D, Saad E
J Genet Eng Biotechnol. 2021; 19(1):141.
PMID: 34568983
PMC: 8473530.
DOI: 10.1186/s43141-021-00244-w.
What Is New on Ovarian Carcinoma: Integrated Morphologic and Molecular Analysis Following the New 2020 World Health Organization Classification of Female Genital Tumors.
De Leo A, Santini D, Ceccarelli C, Santandrea G, Palicelli A, Acquaviva G
Diagnostics (Basel). 2021; 11(4).
PMID: 33919741
PMC: 8070731.
DOI: 10.3390/diagnostics11040697.
Genetic predisposition and prediction protocol for epithelial neoplasms in disease-free individuals: A systematic review.
Gowthami J, Gururaj N, Mahalakshmi V, Sathya R, Sabarinath T, Doss D
J Oral Maxillofac Pathol. 2021; 24(2):293-307.
PMID: 33456239
PMC: 7802851.
DOI: 10.4103/jomfp.JOMFP_348_19.
A comprehensive analysis of somatic alterations in Chinese ovarian cancer patients.
Zhang Y, Shi X, Zhang J, Chen X, Zhang P, Liu A
Sci Rep. 2021; 11(1):387.
PMID: 33432021
PMC: 7801677.
DOI: 10.1038/s41598-020-79694-0.
LRIG1‑2 and LMO7 immunoreactivity in vulvar squamous cell carcinoma: Association with prognosis in relation to HPV‑DNA and p16INK4a status.
Stefansson K, Oda H, Ofverman C, Lundin E, Hedman H, Lindquist D
Oncol Rep. 2019; 42(1):142-150.
PMID: 31059071
PMC: 6549080.
DOI: 10.3892/or.2019.7138.